Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Hilton Hotels Corp. (NYSE: HLT) shares closed up 7.50 percent on Thursday with over 66 million shares traded. The stock made its debut on the NYSE and is the largest hotel IPO ever. HLT was one of the most active stocks in the NYSE as the company raised $2.35 billion on its first day of trading. Hilton Worldwide Holdings Inc. is the world's largest hotel group with 665,667 rooms across 90 countries and territories.
Get more information on Hilton Hotels Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/HLT
CytRx Corporation (NASDAQ: CYTR) shares closed up 52.24 percent on Thursday with over 30 million shares traded. The stock hit a new 52-week high of $6.36 during intra-day trading and was one of the biggest gainers on the NASDAQ. The stock has rallied two trading days after the company reported strong success rates for its cancer treatment aldoxorubicin this past Wednesday.
Get more information on CytRx Corporation and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CYTR
Makism 3D Corp., Inc. (OTCBB: MDDD) shares closed down 29.69 percent on Thursday, retracing from a rally of over 220 percent that started earlier this month. The stock traded about 5.4 million shares and was one of the most actively traded stocks in the OTCBB market. Makism 3D Corp., Inc. designs and manufactures 3D printers for organizations and individuals primarily in the United Kingdom.
Get more information on Makism 3D Corp., Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/MDDD
Provectus Pharmaceuticals, Inc. (OTC: PVCT) shares closed up 16.22 percent on Thursday with over 2 million shares traded. The stock was one of the most active stocks in the OTC market and hit a new 52-week high of $1.30 during intra-day trading. There was no significant news released by the company.
Get more information on Provectus Pharmaceuticals, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/PVCT
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.
Leave a comment...